CFTR modulator theratyping: Current status, gaps and future directionsJohn P. Clancy, Katherine L. Tuggle, Martina Gentzsch et al.|Journal of Cystic Fibrosis|2018Cited by 288
Myofibroblast Differentiation and Enhanced Tgf-B Signaling in Cystic Fibrosis Lung DiseaseWilliam T. Harris, Eric J. Sorscher, David R. Kelly et al.|PLoS ONE|2013Cited by 85
The silent codon change I507‐ATC→ATT contributes to the severity of the ΔF508 CFTR channel dysfunctionAhmed Lazrak, Zsuzsanna Bebök, Lianwu Fu et al.|The FASEB Journal|2013Cited by 70